Journal of Archives in Military Medicine

Published by: Kowsar

Acute Bacterial Meningitis: Diagnosis, Treatment and Prevention

Soheil Mehrdadi 1 , *
Author Information
1 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padua, Italy
Article information
  • Journal of Archives in Military Medicine: 6 (4); e84749
  • Published Online: January 15, 2019
  • Article Type: Review Article
  • Received: September 29, 2018
  • Revised: January 7, 2019
  • Accepted: January 8, 2019
  • DOI: 10.5812/jamm.84749

To Cite: Mehrdadi S. Acute Bacterial Meningitis: Diagnosis, Treatment and Prevention, J Arch Mil Med. Online ahead of Print ; 6(4):e84749. doi: 10.5812/jamm.84749.

Abstract
Copyright © 2019, Journal of Archives in Military Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Dye C. After 2015: Infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130426. doi: 10.1098/rstb.2013.0426. [PubMed: 24821913]. [PubMed Central: PMC4024220].
  • 2. Word Health Organization. The top 10 causes of death. 2017, [May 13, 2018]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/.
  • 3. O'Maonaigh HC, Fisseha S, Thaul S; Institute of Medicine; Medical Follow-up Agency; Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military, et al. Protecting our forces: Improving vaccine acquisition and availability in the U.S. military. National Academies Press; 2002.
  • 4. Siler JF. Army Medical Department in the World War. Vol 9: Communicable and other diseases. Washinnton: U.S. Government Printing Office; 1928. p. 66-70.
  • 5. Gray GC, Feighner B, Trump DH, Berg SW, Zajdowicz MJ, Zajdowicz TR. Disease spread by close personal contact. In: Lenhart MK, Lounsbury DE, editors. Military preventive medicine: Mobilization and deployment, Vol 2. Washington DC: Borden Institute; 2005. p. 1127-8.
  • 6. Bayne-Jones S. The evolution of preventive medicine in the United States Army, 1607-1939. Washington, DC: Office of the Surgeon General, Department of the Army; 1968.
  • 7. Chun CH, Kim SW, Kim WD, Yoon HJ. Changing patterns of epidemiology and death: Causes on epidemic hemorrhagic fever in Korea. Korean J Infect Dis. 1976;8:58-74.
  • 8. Johnson KM. Hantaviruses: History and overview. Curr Top Microbiol Immunol. 2001;256:1-14. [PubMed: 11217399].
  • 9. [No Authors Listed]. The National Security Strategies of the United States of America. 2002. Available from: https://www.state.gov/documents/organization/63562.pdf.
  • 10. Murray CK, Horvath LL. An approach to prevention of infectious diseases during military deployments. Clin Infect Dis. 2007;44(3):424-30. doi: 10.1086/510680. [PubMed: 17205453].
  • 11. Ratto-Kim S, Yoon IK, Paris RM, Excler JL, Kim JH, O'Connell RJ. The US military commitment to vaccine development: A century of successes and challenges. Front Immunol. 2018;9:1397. doi: 10.3389/fimmu.2018.01397. [PubMed: 29977239]. [PubMed Central: PMC6021486].
  • 12. Brundage JF, Zollinger WD. Evolution of meningococcal disease epidemiology in the US Army. In: Vedros NA, editor. Evolution of meningococcal disease. 1. Boca Raton, FL: CRC Press; 1987. p. 6-23.
  • 13. Makras P, Alexiou-Daniel S, Antoniadis A, Hatzigeorgiou D. Outbreak of meningococcal disease after an influenza B epidemic at a Hellenic Air Force recruit training center. Clin Infect Dis. 2001;33(6):e48-50. doi: 10.1086/322609. [PubMed: 11512107].
  • 14. Kushwaha AS, Aggarwal SK, Arora MM. Outbreak of meningococcal infection amongst soldiers deployed in operations. Med J Armed Forces India. 2010;66(1):4-8. doi: 10.1016/S0377-1237(10)80082-6. [PubMed: 27365694]. [PubMed Central: PMC4920896].
  • 15. Jo YM, Bae SM, Kang YH. Cluster of serogroup W-135 meningococcal disease in 3 military recruits. J Korean Med Sci. 2015;30(5):662-5. doi: 10.3346/jkms.2015.30.5.662. [PubMed: 25931801]. [PubMed Central: PMC4414654].
  • 16. Kristiansen BE, Sorensen B, Bjorvatn B, Falk ES, Fosse E, Bryn K, et al. An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol. 1986;23(4):764-7. [PubMed: 3084555]. [PubMed Central: PMC362833].
  • 17. Kadlubowski M, Wasko I, Klarowicz A, Hryniewicz W. Invasive meningococcal disease at a military base in Warsaw, January 2007. Euro Surveill. 2007;12(3). E070301 2. [PubMed: 17439778].
  • 18. Grecki M, Bienias M. Outbreak of invasive meningococcal disease among soldiers in Skwierzyna, Poland, March 2006. Weekly releases (1997–2007). 2006;11(27):2996.
  • 19. Masterton RG, Youngs ER, Wardle JC, Croft KF, Jones DM. Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine. J Infect. 1988;17(2):177-82. [PubMed: 3141518].
  • 20. Koppes GM, Ellenbogen C, Gebhart RJ. Group Y meningococcal disease in United States Air Force recruits. Am J Med. 1977;62(5):661-6. [PubMed: 404877].
  • 21. Smilack JD. Group-y meningococcal disease. Twelve cases at an army training center. Ann Intern Med. 1974;81(6):740-5. [PubMed: 4215351].
  • 22. Brown JW, Condit PK. Meningococcal infections. Fort Ord and California. Calif Med. 1965;102:171-80. [PubMed: 14254973]. [PubMed Central: PMC1515912].
  • 23. Millar JW, Siess EE, Feldman HA, Silverman C, Frank P. In vivo and in vitro resistance to sulfadiazine in strains of neisseria meningitidis. JAMA. 1963;186:139-41. [PubMed: 14056528].
  • 24. Roine I, Peltola H, Fernandez J, Zavala I, Gonzalez Mata A, Gonzalez Ayala S, et al. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis. 2008;46(8):1248-52. doi: 10.1086/533448. [PubMed: 18444863].
  • 25. Portnoy A, Jit M, Lauer J, Blommaert A, Ozawa S, Stack M, et al. Estimating costs of care for meningitis infections in low- and middle-income countries. Vaccine. 2015;33:A240-7. doi: 10.1016/j.vaccine.2014.11.061.
  • 26. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467-92. doi: 10.1128/CMR.00070-09. [PubMed: 20610819]. [PubMed Central: PMC2901656].
  • 27. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci. 2003;4(5):376-85. doi: 10.1038/nrn1103. [PubMed: 12728265].
  • 28. World Health Organization. Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Wkly Epidemiol Rec. 2010;85(43):434-6. [PubMed: 21038716].
  • 29. Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010;10(1):32-42. doi: 10.1016/S1473-3099(09)70306-8. [PubMed: 20129147].
  • 30. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317-28. doi: 10.1016/S1473-3099(10)70048-7. [PubMed: 20417414].
  • 31. Kumar A, Debata PK, Ranjan A, Gaind R. The role and reliability of rapid bedside diagnostic test in early diagnosis and treatment of bacterial meningitis. Indian J Pediatr. 2015;82(4):311-4. doi: 10.1007/s12098-014-1357-z. [PubMed: 24627278].
  • 32. Ginsberg L. Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 1:i16-21. [PubMed: 14978146]. [PubMed Central: PMC1765649].
  • 33. Abdinia B, Ahangarzadeh Rezaee M, Abdoli Oskouie S. Etiology and antimicrobial resistance patterns of acute bacterial meningitis in children: A 10-year referral hospital-based study in northwest iran. Iran Red Crescent Med J. 2014;16(7). e17616. doi: 10.5812/ircmj.17616. [PubMed: 25237583]. [PubMed Central: PMC4166102].
  • 34. Centers for Diseases Control and Prevention. Epidemiology of meningitis caused by Neisseria meningitides, Streptococcus pneumonia and Haemophilus influenza. 2011. Available from: http:www.cdc.gov/meningitis/lab-manual/chpt02-epi.html.
  • 35. Tang LM, Chen ST, Hsu WC, Lyu RK. Acute bacterial meningitis in adults: A hospital-based epidemiological study. QJM. 1999;92(12):719-25. [PubMed: 10581335].
  • 36. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344(18):1378-88. doi: 10.1056/NEJM200105033441807. [PubMed: 11333996].
  • 37. Porto I. Acute bacterial meningitis. US Pharmacist; 2012. Available from: http:www.uspharmacist.com/continuing_education/ceviewtest/lessoned/108112/.
  • 38. Teleb N, Pilishvili T, Van Beneden C, Ghoneim A, Amjad K, Mostafa A, et al. Bacterial meningitis surveillance in the Eastern Mediterranean region, 2005-2010: Successes and challenges of a regional network. J Pediatr. 2013;163(1 Suppl):S25-31. doi: 10.1016/j.jpeds.2013.03.027. [PubMed: 23773590]. [PubMed Central: PMC5801662].
  • 39. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0. [PubMed: 23245604].
  • 40. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-84. doi: 10.1086/425368. [PubMed: 15494903].
  • 41. Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol. 2008;6(8):625-34. doi: 10.1038/nrmicro1952. [PubMed: 18604221]. [PubMed Central: PMC5206914].
  • 42. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999;22:11-28. doi: 10.1146/annurev.neuro.22.1.11. [PubMed: 10202530].
  • 43. Unkmeir A, Latsch K, Dietrich G, Wintermeyer E, Schinke B, Schwender S, et al. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol. 2002;46(4):933-46. [PubMed: 12421301].
  • 44. Stins MF, Badger J, Sik Kim K. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathog. 2001;30(1):19-28. doi: 10.1006/mpat.2000.0406. [PubMed: 11162182].
  • 45. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest. 1998;102(2):347-60. doi: 10.1172/JCI2406. [PubMed: 9664076]. [PubMed Central: PMC508893].
  • 46. Saez-Llorens X, McCracken GH Jr. Meningitis. In: Krugman S, editor. Infectious diseases of children. 9th ed. Mosby-Year Book; 1992. p. 246-59.
  • 47. Stephens DS, Farley MM. Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. Rev Infect Dis. 1991;13(1):22-33. [PubMed: 1901998].
  • 48. Ashwal S, Perkin RM, Thompson JR, Schneider S, Tomasi LG. Bacterial meningitis in children: Current concepts of neurologic management. Adv Pediatr. 1993;40:185-215. [PubMed: 8249704].
  • 49. Musubire AK, Boulware DR, Meya DB, Rhein J. Diagnosis and Management of Cryptococcal Relapse. J AIDS Clin Res. 2013;Suppl 3(3). [PubMed: 24371542]. [PubMed Central: PMC3870901].
  • 50. Geiseler PJ, Nelson KE, Levin S, Reddi KT, Moses VK. Community-acquired purulent meningitis: A review of 1,316 cases during the antibiotic era, 1954-1976. Rev Infect Dis. 1980;2(5):725-45. [PubMed: 6763303].
  • 51. Chavez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(3):795-810. vii. doi: 10.1016/j.pcl.2005.02.011. [PubMed: 15925663].
  • 52. Mace SE. Acute bacterial meningitis. Emerg Med Clin North Am. 2008;26(2):281-317. viii. doi: 10.1016/j.emc.2008.02.002. [PubMed: 18406976].
  • 53. Schutze GE, Mason EO Jr, Barson WJ, Kim KS, Wald ER, Givner LB, et al. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002;21(4):278-82. [PubMed: 12075756].
  • 54. Tunkel AR, Van de Beek D, Scheld MW. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, douglas, and bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2010. p. 1189-229.
  • 55. Bamberger DM. Diagnosis, initial management, and prevention of meningitis. Am Fam Physician. 2010;82(12):1491-8. [PubMed: 21166369].
  • 56. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-59. doi: 10.1056/NEJMoa040845. [PubMed: 15509818].
  • 57. Fraser DW, Geil CC, Feldman RA. Bacterial meningitis in Bernalillo county, New Mexico: A comparison with three other American populations. Am J Epidemiol. 1974;100(1):29-34. [PubMed: 4152262].
  • 58. Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore). 1998;77(5):313-36. [PubMed: 9772921].
  • 59. Shanholtzer CJ, Schaper PJ, Peterson LR. Concentrated gram stain smears prepared with a cytospin centrifuge. J Clin Microbiol. 1982;16(6):1052-6. [PubMed: 6186686]. [PubMed Central: PMC272538].
  • 60. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102(5):1087-97. [PubMed: 9794939].
  • 61. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: Defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108(5):1169-74. [PubMed: 11694698].
  • 62. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev. 1992;5(2):130-45. [PubMed: 1576585]. [PubMed Central: PMC358232].
  • 63. Chiba N, Murayama SY, Morozumi M, Nakayama E, Okada T, Iwata S, et al. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J Infect Chemother. 2009;15(2):92-8. doi: 10.1007/s10156-009-0670-3. [PubMed: 19396518].
  • 64. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39(4):1553-8. doi: 10.1128/JCM.39.4.1553-1558.2001. [PubMed: 11283086]. [PubMed Central: PMC87969].
  • 65. Schuurman T, de Boer RF, Kooistra-Smid AM, van Zwet AA. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol. 2004;42(2):734-40. [PubMed: 14766845]. [PubMed Central: PMC344470].
  • 66. Lu JJ, Perng CL, Lee SY, Wan CC. Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid. J Clin Microbiol. 2000;38(6):2076-80. [PubMed: 10834956]. [PubMed Central: PMC86732].
  • 67. Wu YD, Chen LH, Wu XJ, Shang SQ, Lou JT, Du LZ, et al. Gram stain-specific-probe-based real-time PCR for diagnosis and discrimination of bacterial neonatal sepsis. J Clin Microbiol. 2008;46(8):2613-9. doi: 10.1128/JCM.02237-07. [PubMed: 18550744]. [PubMed Central: PMC2519463].
  • 68. Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M, Foster D, et al. Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: Implication for surveillance and vaccine design. PLoS One. 2008;3(10). e3576. doi: 10.1371/journal.pone.0003576. [PubMed: 18974887]. [PubMed Central: PMC2571985].
  • 69. Dubos F, De la Rocque F, Levy C, Bingen E, Aujard Y, Cohen R, et al. Sensitivity of the bacterial meningitis score in 889 children with bacterial meningitis. J Pediatr. 2008;152(3):378-82. doi: 10.1016/j.jpeds.2007.07.012. [PubMed: 18280844].
  • 70. Seki M, Yamashita Y, Torigoe H, Tsuda H, Sato S, Maeno M. Loop-mediated isothermal amplification method targeting the lytA gene for detection of Streptococcus pneumoniae. J Clin Microbiol. 2005;43(4):1581-6. doi: 10.1128/JCM.43.4.1581-1586.2005. [PubMed: 15814969]. [PubMed Central: PMC1081357].
  • 71. Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies: A review. Nucleosides Nucleotides Nucleic Acids. 2008;27(3):224-43. doi: 10.1080/15257770701845204. [PubMed: 18260008].
  • 72. Ben RJ, Kung S, Chang FY, Lu JJ, Feng NH, Hsieh YD. Rapid diagnosis of bacterial meningitis using a microarray. J Formos Med Assoc. 2008;107(6):448-53. doi: 10.1016/S0929-6646(08)60152-7. [PubMed: 18583215].
  • 73. Wen L, Wang Q, Li Y, Kong F, Gilbert GL, Cao B, et al. Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae). J Clin Microbiol. 2006;44(4):1447-52. doi: 10.1128/JCM.44.4.1447-1452.2006. [PubMed: 16597875]. [PubMed Central: PMC1448623].
  • 74. Korczak B, Frey J, Schrenzel J, Pluschke G, Pfister R, Ehricht R, et al. Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis. J Clin Microbiol. 2005;43(3):1024-31. doi: 10.1128/JCM.43.3.1024-1031.2005. [PubMed: 15750055]. [PubMed Central: PMC1081230].
  • 75. Nigrovic LE, Kuppermann N, Macias CG, Cannavino CR, Moro-Sutherland DM, Schremmer RD, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA. 2007;297(1):52-60. doi: 10.1001/jama.297.1.52. [PubMed: 17200475].
  • 76. Saha SK, Darmstadt GL, Yamanaka N, Billal DS, Nasreen T, Islam M, et al. Rapid diagnosis of pneumococcal meningitis: Implications for treatment and measuring disease burden. Pediatr Infect Dis J. 2005;24(12):1093-8. [PubMed: 16371872].
  • 77. Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. Soluble triggering receptor expressed on myeloid cells 1: A biomarker for bacterial meningitis. Intensive Care Med. 2006;32(8):1243-7. doi: 10.1007/s00134-006-0240-4. [PubMed: 16786330].
  • 78. Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, et al. Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis. 2007;26(9):647-50. doi: 10.1007/s10096-007-0343-z. [PubMed: 17610097].
  • 79. Nigrovic LE, Kuppermann N, Malley R; Bacterial Meningitis Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med. 2008;15(6):522-8. doi: 10.1111/j.1553-2712.2008.00117.x. [PubMed: 18616437].
  • 80. Pedersen TI, Howitz M, Ostergaard C. Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era. Clin Microbiol Infect. 2010;16(5):439-46. doi: 10.1111/j.1469-0691.2009.02841.x. [PubMed: 19548927].
  • 81. Chao YN, Chiu NC, Huang FY. Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect. 2008;41(1):48-53. [PubMed: 18327426].
  • 82. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: A prospective case series. Lancet Neurol. 2006;5(2):123-9. doi: 10.1016/S1474-4422(05)70288-X. [PubMed: 16426988].
  • 83. Heckenberg SGB, de Gans J, Brouwer MC, Weisfelt M, Piet JR, Spanjaard L, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: A prospective cohort study. Medicine. 2008;87(4):185-92.
  • 84. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369(9580):2196-210. doi: 10.1016/S0140-6736(07)61016-2. [PubMed: 17604802].
  • 85. Bronska E, Kalmusova J, Dzupova O, Maresova V, Kriz P, Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect. 2006;12(2):137-41. doi: 10.1111/j.1469-0691.2005.01327.x. [PubMed: 16441451].
  • 86. Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008;122(4):726-30. doi: 10.1542/peds.2007-3275. [PubMed: 18829794].
  • 87. De Cauwer HG, Eykens L, Hellinckx J, Mortelmans LJ. Differential diagnosis between viral and bacterial meningitis in children. Eur J Emerg Med. 2007;14(6):343-7. doi: 10.1097/MEJ.0b013e328270366b. [PubMed: 17968200].
  • 88. Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: A European multicenter case cohort study. Arch Pediatr Adolesc Med. 2008;162(12):1157-63. doi: 10.1001/archpedi.162.12.1157. [PubMed: 19047543].
  • 89. Sormunen P, Kallio MJ, Kilpi T, Peltola H. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr. 1999;134(6):725-9. [PubMed: 10356141].
  • 90. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: A review. J Intensive Care Med. 2007;22(4):194-207. doi: 10.1177/0885066607299516. [PubMed: 17712055].
  • 91. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345(24):1727-33. doi: 10.1056/NEJMoa010399. [PubMed: 11742046].
  • 92. Oliver WJ, Shope TC, Kuhns LR. Fatal lumbar puncture: Fact versus fiction--an approach to a clinical dilemma. Pediatrics. 2003;112(3 Pt 1):e174-6. [PubMed: 12949308].
  • 93. Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23(4):858-83. doi: 10.1128/CMR.00007-10. [PubMed: 20930076]. [PubMed Central: PMC2952976].
  • 94. Brouwer MC, Thwaites GE, Tunkel AR, van de Beek D. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380(9854):1684-92. doi: 10.1016/S0140-6736(12)61185-4. [PubMed: 23141617].
  • 95. van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693-702. doi: 10.1016/S0140-6736(12)61186-6. [PubMed: 23141618].
  • 96. Lieberman JM, Greenberg DP, Ward JI. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis. Infect Dis Clin North Am. 1990;4(4):703-29. [PubMed: 2126022].
  • 97. Schaad UB, abdus Salam M, Aujard Y, Dagan R, Green SD, Peltola H, et al. Use of fluoroquinolones in pediatrics: Consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J. 1995;14(1):1-9. [PubMed: 7715981].
  • 98. Seppa N. Science news. Bacterial meningitis rates fall- Vaccinations cut cases nearly one-third over past decade. 2011. Available from: http:www.usnews.com/science/articles/2011/05/26/bacterial-meningitis-rates-fall.
  • 99. European Medicines Agency. Prevenar: Pneumococcal polysaccharide conjugate vaccine (13-valent,adsorbed). 2012. Available from: http:www.ema.europa.eu/docs/en_GB/document_library/EPAR_Summary_for_the_public/human/001104/WC500057248.pdf.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments